Pathomechanism and clinical signs of mould sensitization in the asthmoid bronchitis syndrome of young children.
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D001183:Arthus Reaction; D001230:Aspergillus / Q000302:isolation & purification; D001249:Asthma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000382:microbiology; D001986:Bronchial Spasm / Q000382:microbiology; D002175:Candida / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D005260:Female; D006168:Guinea Pigs / Q000276:immunology; D006801:Humans; D007223:Infant; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D010866:Natamycin / Q000627:therapeutic use; D010407:Penicillium / Q000302:isolation & purification; D011193:Potassium Iodide / Q000627:therapeutic use; D011859:Radiography; D012882:Skin Tests
D000935:Antifungal Agents; D011193:Potassium Iodide; D010866:Natamycin